AbbVie (ABBV) Other Accumulated Expenses (2012 - 2015)

AbbVie (ABBV) has 4 years of Other Accumulated Expenses data on file, last reported at $2.5 billion in Q4 2015.

• Other Accumulated Expenses for Q4 2015 came in at $2.5 billion, up 31.54% year-over-year; the trailing twelve-month figure through Dec 2015 was $2.5 billion (up 31.54% YoY), and the FY2015 annual result was $2.5 billion, up 31.54% from the prior year.
• Other Accumulated Expenses advanced to $2.5 billion in Q4 2015 per ABBV's latest filing, from $1.9 billion in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $2.5 billion in Q4 2015 and troughed at $1.5 billion in Q4 2013.
• A 4-year average of $1.9 billion and a median of $1.8 billion in 2012 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2013 and 2015: Other Accumulated Expenses slipped 10.88% in 2013, then jumped 31.54% in 2015.
• A 4-year view of Other Accumulated Expenses shows it stood at $1.7 billion in 2012, then declined by 10.88% to $1.5 billion in 2013, then climbed by 26.32% to $1.9 billion in 2014, then jumped by 31.54% to $2.5 billion in 2015.
• Business Quant data shows ABBV's Other Accumulated Expenses at $2.5 billion in Q4 2015, $1.9 billion in Q4 2014, and $1.5 billion in Q4 2013.